What Dovetail’s Envoy Service Is, Why It's Different, and Why It's Working

At Dovetail, we believe in human judgement alongside brilliant AI.

AI has brought unbridled efficiency to our work and intelligence to our fingertips that was previously inaccessible. You could have it build any document with the right context. It’s enough to do just about anything.

But not everything. It still can’t be a human.

It can’t present your product in an FDA pre-submission or structured dialogue. It can’t host your audit. 

While regulations and guidances exist, all regulations are purposefully vague. Regulations and standards change over time, along with how regulators interpret them. 

How would you know this unless you were constantly in the room with regulators? That’s the difference, at Dovetail, we are.

We are in the room with regulators while decisions are made. Our expert team brings this alongside decades of experience to give you an approach and strategy built on proven successes and insider information.

It doesn’t stop there. We custom built an AI-native eQMS with a regulatory intelligence layer to do the work for you. It’s something we’re uniquely trained on to move you quickly. 

Our Envoy service perfectly marries our software infrastructure and dedicated experts for your team. We act as your front of house for regulators while ensuring your back of house is organized and compliant for submission. 

What Envoy actually is

Dovetail is a quality and regulatory partner for medical device companies. You can think of it in three parts that work as one.

Envoy is the senior regulatory team we embed into yours, from pre-market all the way to clearance. An envoy is someone you send to act and negotiate on your behalf. Ours is the person who walks into the FDA pre-sub, the notified-body review, and the audit, and handles the back-and-forth so you don't have to.

Dovetail QMS Plus is the software that the team runs on: an eQMS with an agentic AI layer that drafts technical documentation, searches live regulation, and keeps everything landing as audit-ready evidence. Integrate all your tools into it as your centralized system of record. You keep using it after clearance.

The regulatory intelligence layer is the part you can't buy off a shelf. It's the encoded judgment of experts who have sat across from regulators, built into the system so it doesn't just quote a regulation back at you. Integrations like Slack and our MCP server allow it to be infinitely accessible so you can drive it from the tools you already use, fitting into your team’s workflow.

A note on our name. 

A dovetail joint is one of the oldest forms of precision joinery: two pieces cut to interlock so tightly they hold without glue. Our experts dovetail into your team, our software dovetails into the tools you already use, and the device you've built reaches the people who need it. Each link works cleanly as it locks into the next.

Why we're not just a QMS company

An eQMS used to be the hard part. It isn't anymore. Document builders are close to a commodity, and AI can produce a passable first draft by pulling from regulations and standards.

The trouble is what gets lost in the nuance. AI can be confidently wrong on the questions that matter most, like how your device should be classified or where the scope of your submission should sit. It doesn't know which options have actually been brought to a regulator before and accepted or rejected. It's making an educated guess from a document.

And in regulatory work, early errors don't stay small. Get classification wrong, and your scope is wrong. Wrong scope means the wrong requirements, which corrupts your verification and validation, which sinks the submission before it started. One bad assumption snowballs all the way down.

There's a second problem software can't see: regulatory drift. How auditors interpret a regulation shifts over time, and that interpretation isn't published anywhere. You only learn it by being in the room. A model trained last year can be confidently, expensively out of date.

So the software handles the volume, the experts catch the things that compound and the regulatory intelligence layer grows with you. In perfect harmony.

Why we're not calling ourselves a consulting agency

Traditional consultants advise from the outside. They tell you what to do, then hand it back for you to file, hire around, and defend on your own.

We represent you. We stand in front of the FDA and the notified body, in the meetings that decide your timeline, not just in the slide deck that prepares for them. Being in the room is what separates this from consulting, because someone who has been across the table from a regulator carries weight that an external adviser simply doesn't.

They also don’t build the next generation of tools to be used by our trade. That is what we live and breathe, amazing outcomes for you and even better tooling to get us there.

It also means our advice doesn't fall into a gap. A consultant who isn't plugged into your quality system gives guidance that never makes it into the file. Because our team lives inside the same eQMS your evidence lands in, the strategy and the documentation stay locked together instead of drifting apart.

Why the combination beats the sum of its parts

Take any one piece on its own and it's ordinary. An eQMS is ordinary. A regulatory consultant is ordinary. An AI that drafts documents is now ordinary too.

Locked together, they stop being ordinary:

• The experts make the AI trustworthy, because someone with accountability keeps the judgment.
• The AI is customized to our experts to make them fast, by doing the drafting and searching precisely how they want it to.
• The QMS is built by the people who use it and has been battle tested through audits and submissions.

That's the four-fold chain that gets a device through: agentic AI to human expert to your product team to the market and the patients

Why it's working

The model is built for the place founders feel most exposed: clear runway limits, with the regulatory pathway as the biggest unknown between them and the market. Embedding a senior team there, instead of leaving a founder to hire a full in-house function they can't yet afford, de-risks the whole roadmap.

The numbers our clients see bear it out: a team with 80+ successful certifications, a 100% audit success rate, three regulatory markets covered in parallel, and an average of €70K+ in avoided costs from getting it right the first time.

The shortest path to market

Not by rushing a safety-critical process. By knowing the terrain well enough to skip the detours: the rework, the re-submission, the avoidable rejection. Real experts in the room, a validated eQMS and a regulatory intelligence layer behind them, and no in-house team to hire before you're ready.

If you're building a medical device and the regulatory path is the thing standing between you and the market, that's exactly what Envoy is for.